Keyphrases
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Methylation Panel
100%
High-risk Human Papillomavirus (HR-HPV)
100%
DNA Methylation (DNAm)
100%
Tumor
33%
Host DNA
33%
Oropharyngeal
22%
Cancer-specific Survival
22%
Squamous Cell Carcinoma (SqCC)
22%
Cyclin-dependent Kinase Inhibitor 2A (CDKN2A)
22%
Clinical Significance
22%
HPV16 E7
11%
Methylation Status
11%
Effector Proteins
11%
Golden Standard
11%
CpG Loci
11%
Molecular Characterization
11%
Clinical Outcomes
11%
Methylation Test
11%
Functional Relevance
11%
E7 Oncogene
11%
Tumor Progression
11%
DNA Methylation Status
11%
Hypermethylated
11%
Clinical Utility
11%
Clinical Samples
11%
Cancer Tumor
11%
HPV16 Infection
11%
Biochemistry, Genetics and Molecular Biology
Wart Virus
100%
DNA Methylation
100%
RNA
22%
Methylation
22%
Human Papillomavirus Type 16
22%
P16
22%
Cancer Survival
22%
Cyclin Dependent Kinase Inhibitor 2A
22%
Tumor Progression
11%
Clinical Study
11%
Oncogene
11%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus
100%
Human Papillomavirus Type 16
22%
Cancer Survival
22%
Cyclin Dependent Kinase Inhibitor 2A
22%
Neoplasm
11%
Infection
11%
Tumor Growth
11%
Clinical Study
11%